Clinical trial
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal…
NCT00360529 · Sprout Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00360529 |
|---|---|
| Title | 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder |
| Official title | A Twenty Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 50mg Every Evening and Flibanserin 100mg Every Evening in Women With Hypoactive Sexual Desire Disorder in North America |
| Lead sponsor | Sprout Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunctions, Psychological |
| Intervention type | Drug |
| Interventions | flibanserin |
| Enrollment | 880 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Jun 27, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: